PHILADELPHIA, PA and NEW YORK, NY (APRIL 17, 2018) – PRESS RELEASE – Tikun Olam, a cannabis science and cannabis wellness brand, and Ilera Healthcare, a Pennsylvania medical marijuana cultivator, processor and dispenser, have finalized a deal to bring Tikun’s medical marijuana strains to medical cannabis patients in the Keystone State later this year, according to a press release.
This partnership combines Tikun Olam’s history of peer-reviewed scientific research and unprecedented clinical data collection with Ilera’s expertise in formulating and delivering high-quality pharmaceutical-grade medical cannabis products to Pennsylvanians. Products developed from Tikun Olam’s proprietary strains, including its world-renowned Avidekel high-CBD strain, will be available in vape oils, tinctures and topical formulations.
Tikun Olam has created numerous cannabis strains designed to deliver symptomatic relief for specific conditions in line with the 17 medical conditions approved for medical cannabis use in Pennsylvania, including autism, cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few.
“Tikun Olam has spent years developing our strains through scientific methods,” says Tikun CEO Bernie Sucher. “Finding the ideal partner that shares our focus on quality control and consistency from seed to sale was a top priority for our Pennsylvania launch, and Ilera Healthcare was our top choice.”
Greg Rochlin, CEO of Ilera Healthcare, sees this as a natural partnership. “Ilera is dedicated to producing consistent, high-quality medications with effects that are supported by data, and so is Tikun Olam.”
